Portal de investigación
Adalimumab in prevention of postoperative recurrence of Crohn's disease in high-risk patients.
Fecha de publicación:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Muñoz F
- Barrio J
- Riestra S
Grupos
Abstract
To evaluate the effectiveness of adalimumab in preventing recurrence after intestinal resection for Crohn's disease in high-risk patients.
Datos de la publicación
- ISSN/ISSNe:
- 1007-9327, 2219-2840
- Tipo:
- Article
- Páginas:
- 4391-4398
- PubMed:
- 22969204
- Factor de Impacto:
- 0,922 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
WORLD JOURNAL OF GASTROENTEROLOGY BAISHIDENG PUBLISHING GROUP INC
Citas Recibidas en Web of Science: 71
Documentos
- No hay documentos
Filiaciones
Keywords
- Adalimumab, Crohn’s disease, Postoperative recurrence, Prevention, Tumor necrosis factor alpha agents
Campos de Estudio
Cita
AGUAS M,BASTIDA G,CERRILLO E,BELTRÁN B,IBORRA M,SÁNCHEZ C,Muñoz F,Barrio J,Riestra S,NOS P. Adalimumab in prevention of postoperative recurrence of Crohn's disease in high-risk patients. World J. Gastroenterol. 2012. 18. (32):p. 4391-4398. IF:2,547. (2).